Australia markets closed

ABBV Jan 2024 115.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
6.350.00 (0.00%)
As of 02:33PM EDT. Market open.
Full screen
Previous close6.35
Open6.35
Bid6.25
Ask8.05
Strike115.00
Expiry date2024-01-19
Day's range6.35 - 6.35
Contract rangeN/A
Volume1
Open interest50
  • Motley Fool

    This Blockbuster Drug from AbbVie Is Closer to Another Major Indication

    The European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) recently adopted a positive opinion that recommended the approval of AbbVie's (NYSE: ABBV) Rinvoq for what would be its fifth indication in that market. This would be to treat patients with moderate-to-severe ulcerative colitis who had an inadequate response to conventional therapies or biologic agents. A decision for Rinvoq as a treatment for moderate-to-severe ulcerative colitis patients from the European Commission is expected in the third quarter of this year.

  • Motley Fool

    3 Stocks You Can Buy and Hold for Decades

    Three little words can make you a lot of money over the long term: Buy and hold. Here's why they picked AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (AbbVie): Pharma giant AbbVie is currently defying gravity.

  • Motley Fool

    Amgen's Beating the Market -- Here's Why It's a Buy Now

    A blockbuster could be on the way next year -- but if you wait that long to invest, could it be too late?